首页> 中文期刊> 《实用心脑肺血管病杂志》 >氨氯地平联合厄贝沙坦治疗老年(≥80岁)高血压的临床疗效观察

氨氯地平联合厄贝沙坦治疗老年(≥80岁)高血压的临床疗效观察

摘要

目的:观察氨氯地平联合厄贝沙坦治疗老年(≥80岁)高血压的临床疗效。方法选择2012年6月-2013年12月我院内科门急诊收治的老年(≥80岁)高血压患者66例,将其随机分为观察组34例和对照组32例。对照组给予氨氯地平治疗,观察组给予氨氯地平联合厄贝沙坦治疗。4周为1个疗程,比较两组患者治疗前后血压变化、临床疗效及治疗期间不良反应情况。结果观察组总有效率为94.1%,高于对照组的71.9%(P <0.05)。治疗前两组患者舒张压和收缩压比较,差异无统计学意义(P >0.05);治疗后观察组患者舒张压和收缩压低于对照组(P <0.05);观察组不良反应发生率为11.8%,对照组为12.5%,差异无统计学意义(P >0.05)。结论氨氯地平联合厄贝沙坦治疗老年(≥80岁)高血压安全有效。%Objective To observe the clinical effect of amlodipine combined with irbesartan on hypertension in elderly (≥80 years old)patients. Methods From June 2012 to December 2013,66 elderly(≥80 years old)hypertension patients admitted to our hospital were selected and randomly divided into control group(n = 32)and observation group(n = 34). Con-trol group was treated with amlodipine,while observation group treated with amlodipine combined with irbesartan,both groups treated for 4 weeks. Blood pressure before and after treatment,total clinical effective rate and incidence of adverse reactions dur-ing treatment were compared between the two groups. Results The total clinical effective rate of observation group was 94. 1% , was higher than that of control group of 71. 9% (P < 0. 05). There was no significant differences of DBP and SBP between the two groups before treatment(P > 0. 05),but DBP and SBP of observation group were lower than those of control group(P <0. 05). Incidence of adverse reactions during treatment of observation group was 11. 8% ,that of control group was 12. 5% ,the difference was not significantly different(P > 0. 05). Conclusion Amlodipine combined with irbesartan is effective and safe on hypertension in elderly(≥80 years)patients.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号